Economic evaluation of sublingual immunotherapy

an analysis of literature.

G. Ciprandi, F. Agostinis, S. Amoroso, R. Ariano, A. Barbato, M. Bassi, G. Cadario, P. Campi, F. Cardinale, C. Romano, C. Incorvaia, R. Danneo, S. Dal Bo, M. Di Gioacchino, A. Fiocchi, M. Galimberti, E. Galli, M. Giovannini, S. La Grutta, Carlo Lombardi & 21 others F. Marcucci, G. L. Marseglia, F. Mastrandrea, M. Minelli, E. Nettis, E. Novembre, C. Ortolani, G. Pajno, P. P. Piras, G. Passalacqua, G. Patriarca, S. Pucci, O. Quercia, A. Romano, D. Schiavino, M. Sforza, M. A. Tosca, S. Tripodi, M. Zambito, P. Puccinelli, F. Frati

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Allergic rhinitis and asthma constitute a global health problem because of their very high prevalence and the consequent burden of disease, concerning medical and economical issues. Among the treatments of allergy, specific immunotherapy has the capacity to favourably alter the natural history of the disease both during and after its performance and thus to reduce the direct and indirect costs of allergic rhinitis and asthma. A number of studies reported such cost reduction for traditional, subcutaneous immunotherapy and recent data demonstrate that also sublingual immunotherapy (SLIT) is associated to economic advantages and/or monetary savings, specifically in terms of reduction of disease economic burden. Only few formal economic assessments of SLIT have been carried out so far, this article will present and discuss the published studies addressed to this issue. The data obtained, although the number of studies is still limited, provide preliminary evidence supporting a SLIT effect on sparing costs for respiratory allergy.

Original languageEnglish
Pages (from-to)21-26
Number of pages6
JournalEuropean Annals of Allergy and Clinical Immunology
Volume39 Spec No
Publication statusPublished - 2007

Fingerprint

Sublingual Immunotherapy
Cost-Benefit Analysis
Costs and Cost Analysis
Immunotherapy
Hypersensitivity
Asthma
Economics
Cost of Illness
Allergic Rhinitis
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ciprandi, G., Agostinis, F., Amoroso, S., Ariano, R., Barbato, A., Bassi, M., ... Frati, F. (2007). Economic evaluation of sublingual immunotherapy: an analysis of literature. European Annals of Allergy and Clinical Immunology, 39 Spec No, 21-26.

Economic evaluation of sublingual immunotherapy : an analysis of literature. / Ciprandi, G.; Agostinis, F.; Amoroso, S.; Ariano, R.; Barbato, A.; Bassi, M.; Cadario, G.; Campi, P.; Cardinale, F.; Romano, C.; Incorvaia, C.; Danneo, R.; Dal Bo, S.; Di Gioacchino, M.; Fiocchi, A.; Galimberti, M.; Galli, E.; Giovannini, M.; La Grutta, S.; Lombardi, Carlo; Marcucci, F.; Marseglia, G. L.; Mastrandrea, F.; Minelli, M.; Nettis, E.; Novembre, E.; Ortolani, C.; Pajno, G.; Piras, P. P.; Passalacqua, G.; Patriarca, G.; Pucci, S.; Quercia, O.; Romano, A.; Schiavino, D.; Sforza, M.; Tosca, M. A.; Tripodi, S.; Zambito, M.; Puccinelli, P.; Frati, F.

In: European Annals of Allergy and Clinical Immunology, Vol. 39 Spec No, 2007, p. 21-26.

Research output: Contribution to journalArticle

Ciprandi, G, Agostinis, F, Amoroso, S, Ariano, R, Barbato, A, Bassi, M, Cadario, G, Campi, P, Cardinale, F, Romano, C, Incorvaia, C, Danneo, R, Dal Bo, S, Di Gioacchino, M, Fiocchi, A, Galimberti, M, Galli, E, Giovannini, M, La Grutta, S, Lombardi, C, Marcucci, F, Marseglia, GL, Mastrandrea, F, Minelli, M, Nettis, E, Novembre, E, Ortolani, C, Pajno, G, Piras, PP, Passalacqua, G, Patriarca, G, Pucci, S, Quercia, O, Romano, A, Schiavino, D, Sforza, M, Tosca, MA, Tripodi, S, Zambito, M, Puccinelli, P & Frati, F 2007, 'Economic evaluation of sublingual immunotherapy: an analysis of literature.', European Annals of Allergy and Clinical Immunology, vol. 39 Spec No, pp. 21-26.
Ciprandi G, Agostinis F, Amoroso S, Ariano R, Barbato A, Bassi M et al. Economic evaluation of sublingual immunotherapy: an analysis of literature. European Annals of Allergy and Clinical Immunology. 2007;39 Spec No:21-26.
Ciprandi, G. ; Agostinis, F. ; Amoroso, S. ; Ariano, R. ; Barbato, A. ; Bassi, M. ; Cadario, G. ; Campi, P. ; Cardinale, F. ; Romano, C. ; Incorvaia, C. ; Danneo, R. ; Dal Bo, S. ; Di Gioacchino, M. ; Fiocchi, A. ; Galimberti, M. ; Galli, E. ; Giovannini, M. ; La Grutta, S. ; Lombardi, Carlo ; Marcucci, F. ; Marseglia, G. L. ; Mastrandrea, F. ; Minelli, M. ; Nettis, E. ; Novembre, E. ; Ortolani, C. ; Pajno, G. ; Piras, P. P. ; Passalacqua, G. ; Patriarca, G. ; Pucci, S. ; Quercia, O. ; Romano, A. ; Schiavino, D. ; Sforza, M. ; Tosca, M. A. ; Tripodi, S. ; Zambito, M. ; Puccinelli, P. ; Frati, F. / Economic evaluation of sublingual immunotherapy : an analysis of literature. In: European Annals of Allergy and Clinical Immunology. 2007 ; Vol. 39 Spec No. pp. 21-26.
@article{6d0d438f60f345ffa9b13e860ef5d997,
title = "Economic evaluation of sublingual immunotherapy: an analysis of literature.",
abstract = "Allergic rhinitis and asthma constitute a global health problem because of their very high prevalence and the consequent burden of disease, concerning medical and economical issues. Among the treatments of allergy, specific immunotherapy has the capacity to favourably alter the natural history of the disease both during and after its performance and thus to reduce the direct and indirect costs of allergic rhinitis and asthma. A number of studies reported such cost reduction for traditional, subcutaneous immunotherapy and recent data demonstrate that also sublingual immunotherapy (SLIT) is associated to economic advantages and/or monetary savings, specifically in terms of reduction of disease economic burden. Only few formal economic assessments of SLIT have been carried out so far, this article will present and discuss the published studies addressed to this issue. The data obtained, although the number of studies is still limited, provide preliminary evidence supporting a SLIT effect on sparing costs for respiratory allergy.",
author = "G. Ciprandi and F. Agostinis and S. Amoroso and R. Ariano and A. Barbato and M. Bassi and G. Cadario and P. Campi and F. Cardinale and C. Romano and C. Incorvaia and R. Danneo and {Dal Bo}, S. and {Di Gioacchino}, M. and A. Fiocchi and M. Galimberti and E. Galli and M. Giovannini and {La Grutta}, S. and Carlo Lombardi and F. Marcucci and Marseglia, {G. L.} and F. Mastrandrea and M. Minelli and E. Nettis and E. Novembre and C. Ortolani and G. Pajno and Piras, {P. P.} and G. Passalacqua and G. Patriarca and S. Pucci and O. Quercia and A. Romano and D. Schiavino and M. Sforza and Tosca, {M. A.} and S. Tripodi and M. Zambito and P. Puccinelli and F. Frati",
year = "2007",
language = "English",
volume = "39 Spec No",
pages = "21--26",
journal = "Allergie et Immunologie",
issn = "0397-9148",
publisher = "Mattioli 1885 S.p.A.",

}

TY - JOUR

T1 - Economic evaluation of sublingual immunotherapy

T2 - an analysis of literature.

AU - Ciprandi, G.

AU - Agostinis, F.

AU - Amoroso, S.

AU - Ariano, R.

AU - Barbato, A.

AU - Bassi, M.

AU - Cadario, G.

AU - Campi, P.

AU - Cardinale, F.

AU - Romano, C.

AU - Incorvaia, C.

AU - Danneo, R.

AU - Dal Bo, S.

AU - Di Gioacchino, M.

AU - Fiocchi, A.

AU - Galimberti, M.

AU - Galli, E.

AU - Giovannini, M.

AU - La Grutta, S.

AU - Lombardi, Carlo

AU - Marcucci, F.

AU - Marseglia, G. L.

AU - Mastrandrea, F.

AU - Minelli, M.

AU - Nettis, E.

AU - Novembre, E.

AU - Ortolani, C.

AU - Pajno, G.

AU - Piras, P. P.

AU - Passalacqua, G.

AU - Patriarca, G.

AU - Pucci, S.

AU - Quercia, O.

AU - Romano, A.

AU - Schiavino, D.

AU - Sforza, M.

AU - Tosca, M. A.

AU - Tripodi, S.

AU - Zambito, M.

AU - Puccinelli, P.

AU - Frati, F.

PY - 2007

Y1 - 2007

N2 - Allergic rhinitis and asthma constitute a global health problem because of their very high prevalence and the consequent burden of disease, concerning medical and economical issues. Among the treatments of allergy, specific immunotherapy has the capacity to favourably alter the natural history of the disease both during and after its performance and thus to reduce the direct and indirect costs of allergic rhinitis and asthma. A number of studies reported such cost reduction for traditional, subcutaneous immunotherapy and recent data demonstrate that also sublingual immunotherapy (SLIT) is associated to economic advantages and/or monetary savings, specifically in terms of reduction of disease economic burden. Only few formal economic assessments of SLIT have been carried out so far, this article will present and discuss the published studies addressed to this issue. The data obtained, although the number of studies is still limited, provide preliminary evidence supporting a SLIT effect on sparing costs for respiratory allergy.

AB - Allergic rhinitis and asthma constitute a global health problem because of their very high prevalence and the consequent burden of disease, concerning medical and economical issues. Among the treatments of allergy, specific immunotherapy has the capacity to favourably alter the natural history of the disease both during and after its performance and thus to reduce the direct and indirect costs of allergic rhinitis and asthma. A number of studies reported such cost reduction for traditional, subcutaneous immunotherapy and recent data demonstrate that also sublingual immunotherapy (SLIT) is associated to economic advantages and/or monetary savings, specifically in terms of reduction of disease economic burden. Only few formal economic assessments of SLIT have been carried out so far, this article will present and discuss the published studies addressed to this issue. The data obtained, although the number of studies is still limited, provide preliminary evidence supporting a SLIT effect on sparing costs for respiratory allergy.

UR - http://www.scopus.com/inward/record.url?scp=55449129957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55449129957&partnerID=8YFLogxK

M3 - Article

VL - 39 Spec No

SP - 21

EP - 26

JO - Allergie et Immunologie

JF - Allergie et Immunologie

SN - 0397-9148

ER -